On April 22, 2016, a couple from Illinois filed an Invokana lawsuit in the District of New Jersey, Trenton Division. They named manufacturers Janssen Pharmaceuticals and parent company Johnson & Johnson (J&J) as defendants. This is one of many cases that have been filed concerning…
Recent studies have raised concerns that people using common heartburn drugs like Nexium and Prilosec may be at an increased risk for serious kidney problems, including chronic kidney disease (CKD) and kidney failure. Many healthcare professionals have raised concerns that Americans are overusing th
In June 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all testosterone replacement lawsuits into one court in the Northern District of Illinois. Since then, both sides have been working to select a group of potential cases for early trials. In a Case…
On May 10, 2016, five children filed a new Invokana lawsuit on behalf of their deceased mother. The case was filed in the U.S. District Court for the Middle District of Louisiana. The plaintiffs name manufacturers Janssen Pharmaceuticals and parent company Johnson & Johnson (J&J)…
After May 19, 2016, plaintiffs will no longer be able to file joint complaints in the Xarelto MDL currently proceeding in the Eastern District of Louisiana. After that, only individual complaints will be allowed. All federal Xarelto lawsuits were consolidated there in December 2014, and…
The number of lawsuits filed against diabetes drug Invokana manufacturer Janssen Pharmaceuticals (and parent company Johnson & Johnson) continues to increase. On March 31, 2016, a new case was filed in the Superior Court of the State of Delaware. The plaintiff, a Tennessee resident, claims…
On March 17, 2016, a Louisiana man filed an Invokana lawsuit against manufacturers Janssen Pharmaceuticals, parent company Johnson & Johnson (J&J) and Mitsubishi Tanabe Pharma Corp. He seeks in excess of $75,000 in damages. The case is proceeding in the U.S. District Court for the…
In December 2014, all federally filed Xarelto lawsuits were consolidated into the Eastern District of Louisiana for pre-trial proceedings. Since then, the court has seen a steady increase in the number of cases there. Another new lawsuit joined the MDL on March 16, 2016. The…
In February 2014, the FDA issued a drug safety communication stating that they were investigating a possible association between type 2 diabetes drug Onglyza (saxagliptin) and heart failure. After further analysis, they confirmed that the drug did increase risk of hospitalization for heart risk fail
In June 2014, the U.S. Judicial Panel for Multidistrict Litigation (JPML) consolidated all federal testosterone lawsuits into the Northern District of Illinois for pre-trial proceedings. Both the plaintiffs and the defendants requested that a similar consolidation take place in Pennsylvania state co
On December 12, 2014, the U.S. Judicial Panel on Multidistrict Litigation consolidated all federally filed Xarelto lawsuits into one court in the Eastern District of Louisiana. Since then, the parties have been involved in choosing potential cases to proceed to early bellwether trials. In a…
The European Medicines Agency’s (EMA’s) Pharmocovigilance Risk Assessment Committee (PRAC) recently finalized their review of SGLT2 inhibitors—type 2 diabetes drugs including Invokana. They concluded that additional recommendations were needed to help minimize the risk of one potentially dangerous s